IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 381 - 400 of 1110 stories.
October 2, 2012
BASF to move pharma ingredients headquarters to US, appoints new business head BASF says it will relocate the global headquarters of the pharma ingredients and services business unit...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-October-2_46641.html
October 2, 2012
Mitsubishi Gas Chemical (MGC) says it will stop the manufacture and sale of coenzyme Q10, a material for pharmaceuticals and health food, due to poor profitability of the business...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mitsubishi-Gas-Chemical-exits-coenzyme-Q10-business_46634.html
October 1, 2012
Ashland says it will open a new pharmaceutical application laboratory at Düsseldorf in December 2012. The laboratory will provide technical support to Ashland’s European...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ashland-to-open-pharmaceutical-lab-in-Germany_46593.html
September 27, 2012
The European Commission has made two proposals to close loopholes in current European Union (EU) legislation on precursors for the illegal drugs methamphetamine and heroin. The...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EU-Commission-Proposes-Tighter-Controls-on-Precursors-for-Illegal-Drugs_46550.html
September 27, 2012
Lonza says that biopharmaceutical company Intellect Neurosciences (New York) has awarded the future development and manufacture of the antibody-drug conjugate Conjumab-A to Lonza...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-to-Develop-Manufacture-U-S-Biopharma-Firms-Antibody-Drug-Conjugate_46545.html
September 25, 2012
FINE CHEMICALS: STAYING ACTIVE The global active pharmaceutical ingredient (API) industry is very competitive, and manufacturers are faced with several challenges, including pricing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-September-25_46501.html
September 25, 2012
Carbogen Amcis (Bubendorf, Switzerland), a pharma process-development and active pharmaceutical ingredient (API) manufacturing subsidiary of Dishman Pharmaceuticals and Chemicals...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Carbogen-Amcis-Partners-with-ADC-Biotechnology_46499.html
September 25, 2012
The manufacture of active pharmaceutical ingredients (APIs) will account for the majority of revenues in the pharmaceutical contract manufacturing industry in the next 10 years, says a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/APIs-Will-Drive-Growth-in-Contract-Manufacturing_46498.html
September 18, 2012
IMCD ACQUIRES PHARMA INGREDIENTS DISTRIBUTOR IN MALAYSIA Distributor IMCD Group (Rotterdam), says it has acquired the pharmaceutical ingredients distribution business of Maxwell Pharma...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-September-18_46331.html
September 18, 2012
Distributor IMCD Group (Rotterdam) says it has acquired the pharmaceutical ingredients distribution business of Maxwell Pharma (Petaling Jaya, Malaysia), a privately owned company...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/IMCD-Acquires-Pharma-Ingredients-Distributor-in-Malaysia_46330.html
September 11, 2012
CAMBRIDGE MAJOR EXPANDS API FACILITY Cambridge Major Laboratories (CML; Germantown, WI) says it has significantly expanded its active pharmaceutical ingredient (API) manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-September-11_46167.html
September 11, 2012
Unipex Group (Paris) says its current owner, AXA Private Equity (Paris), has reached an agreement to sell 100% of its interest in Unipex, to the IK2007 Fund, advised by private equity...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Unipex-Group-Changes-Private-Equity-Hands_46162.html
September 10, 2012
Cambridge Major Laboratories (CML; Germantown, WI) says it has significantly expanded its active pharmaceutical ingredient (API) manufacturing facility at Germantown, following...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambridge-Major-Expands-API-Facility_46130.html
September 4, 2012
HOSPIRA TO ACQUIRE API FACILITY IN INDIA FOR $200 MILLION Hospira (Lake Forest, IL), the world's leading provider of injectable drugs and infusion technologies, says it has signed an...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-September-4_46013.html
September 4, 2012
Codexis (Redwood City, CA) says it has appointed David O’Toole as senior v.p. and CFO, effective September 4. Codexis announced in June 2012 that its interim CFO, Brian Dowd, had...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Codexis-Appoints-New-CFO_46012.html
August 30, 2012
Siegfried (Zofingen, Switzerland), a producer of active pharmaceutical ingredients (APIs), intermediates, and finished drugs, reported nearly a seven-fold increase in net profits in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Siegfried-Reports-Huge-Rise-in-Profits-Amid-Expansions_45908.html
August 29, 2012
Hospira (Lake Forest, IL), the world's leading provider of injectable drugs and infusion technologies, says it has signed an agreement to acquire an active pharmaceutical ingredient...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hospira-to-Acquire-API-Facility-in-India-for-$200-Million_45881.html
August 28, 2012
MANUFACTURERS REQUIRE TO SELF-IDENTIFY UNDER GDUFA The U.S. FDA is establishing a new system for the electronic self-identification of generic industry facilities, sites, and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-August-28_45850.html
August 21, 2012
CAMBREX SIGNS API MANUFACTURING DEAL, TO EXPAND PRODUCTION CAPACITY Cambrex (East Rutherford, NJ) says it has entered into an agreement to supply an active pharmaceutical ingredient...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-August-21_45753.html
August 17, 2012
The active pharmaceutical ingredient (API) business segment of Perrigo (Allegan, MI) reported a 4.3% rise in sales in its fiscal fourth quarter, ended June 30, 2012, compared with the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Perrigos-API-Business-Reports-Rise-in-Sales-Operating-Profits_45709.html
Pages: « Previous  11 12 13 14 15 16 17 18 19 [20] 21 22 23 24 25 26 27 28 29 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa